Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.1%

9 terminated/withdrawn out of 217 trials

Success Rate

90.7%

+4.2% vs industry average

Late-Stage Pipeline

8%

18 trials in Phase 3/4

Results Transparency

8%

7 of 88 completed trials have results

Key Signals

31 recruiting7 with results8 terminated

Enrollment Performance

Analytics

N/A
79(58.1%)
Phase 2
28(20.6%)
Phase 3
12(8.8%)
Phase 1
9(6.6%)
Phase 4
6(4.4%)
Early Phase 1
2(1.5%)
136Total
N/A(79)
Phase 2(28)
Phase 3(12)
Phase 1(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (217)

Showing 20 of 217 trials
NCT07725926Not ApplicableRecruiting

Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

Role: lead

NCT07717632Not ApplicableActive Not Recruiting

AI-enhanced LF-MRI in Epilepsy

Role: collaborator

NCT05579496Recruiting

Rebooting Infant Pain Care: Using Machine Learning and Skin-to-Skin Contact to Exponentially Improve Neonatal Intensive Care Unit Practice

Role: collaborator

NCT06183437Phase 4Recruiting

The STOP-MED CTRCD Trial

Role: collaborator

NCT04851470Recruiting

Periodontal Assessment of a Bariatric Care Population

Role: collaborator

NCT05088213Not ApplicableCompleted

Suction Mini-PCNL Versus Standard PCNL for the Management of 2-4cm Kidney Stones

Role: collaborator

NCT05537220Phase 3Active Not Recruiting

Oral N-acetylcysteine for Retinitis Pigmentosa

Role: collaborator

NCT03981575Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Role: collaborator

NCT04844775Phase 1Completed

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Role: collaborator

NCT03050931Active Not Recruiting

Electrical Impedance Tomography of Epilepsy

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT04995224Recruiting

Mechanism of Chronic Pain in Patients With IBD

Role: collaborator

NCT03684564Phase 2Completed

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Role: collaborator

NCT07592247Not ApplicableNot Yet Recruiting

Potential for Recovery of Voluntary Finger Extension After Stroke

Role: collaborator

NCT06815120Not ApplicableRecruiting

A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

Role: collaborator

NCT07568366Early Phase 1Not Yet Recruiting

AI in Endoscopic Transsphenoidal Surgery

Role: collaborator

NCT02914405Phase 1Active Not Recruiting

Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma

Role: collaborator

NCT07549893Not ApplicableNot Yet Recruiting

Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma (BURR-MMA)

Role: collaborator

NCT05197322Phase 2Recruiting

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Role: collaborator

NCT07386652Not ApplicableNot Yet Recruiting

Intensive Comprehensive Aphasia Programme for People With Post-Stroke Aphasia

Role: collaborator